FDA UNTITLED_LETTER - STAQ Pharma of Ohio, LLC - May 06, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns STAQ Pharma of Ohio, LLC, with an inspection on May 6, 2025, issued by the Center for Drug Evaluation and Research.

Company: STAQ Pharma of Ohio, LLC
Inspection Date: May 6, 2025
Office: Center for Drug Evaluation and Research
People: Joseph Bagan (Chief Executive Officer)
Frances G. Bormel (Director)

Open in Dashboard

ID · 68bc113a-f5a7-4210-9008-f10d4c81dce4

Violation Codes10

21 U.S.C. 331(a)21 U.S.C. 331(k)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 CFR 211(c)(2)21 U.S.C. 353b21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 CFR 211(a)

Full citation text and observation details available on the Dashboard.